Companhia Brasileira De Distribuicao
(NYSE:CBD)
$0.74
0[0.00%]
Last update: 7:00PM (Delayed 15-Minutes)
Get Real Time Here
$0.749
0.0090[1.22%]
Open-Close-
Vol / Avg.142.000 / 1.410MMkt Cap199.785M
Day Range- - -52 Wk Range0.740 - 4.760

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Companhia Brasileira Stock (NYSE:CBD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$0.00

Lowest Price Target1

$0.00

Consensus Price Target1

$0.00

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
10000

Analyst Firms Making Recommendations1

  • B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Companhia Brasileira

All Ratings (2)

Upgrades (1)

Downgrades (1)

Initiations (0)

Q

What is the target price for Companhia Brasileira (CBD)?

A

The latest price target for Companhia Brasileira (NYSE: CBD) was reported by B of A Securities on May 4, 2022. The analyst firm set a price target for $0.00 expecting CBD to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Companhia Brasileira (CBD)?

A

The latest analyst rating for Companhia Brasileira (NYSE: CBD) was provided by B of A Securities, and Companhia Brasileira upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Companhia Brasileira (CBD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Companhia Brasileira, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Companhia Brasileira was filed on May 4, 2022 so you should expect the next rating to be made available sometime around May 4, 2023.

Q

Is the Analyst Rating Companhia Brasileira (CBD) correct?

A

While ratings are subjective and will change, the latest Companhia Brasileira (CBD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Companhia Brasileira (CBD) is trading at is $0.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.